References: Clinical features and diagnosis of heparin-induced thrombocytopenia

  • Joseph J, Rabbolini D, Enjeti AK, Favaloro E, Kopp MC, McRae S, et al. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group. Med J Aust 2019;210(11):509-16. https://www.ncbi.nlm.nih.gov/pubmed/31155728
  • Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. Blood 2015;125(6):924-9. https://www.ncbi.nlm.nih.gov/pubmed/25515959
  • Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005;106(8):2710-5. https://www.ncbi.nlm.nih.gov/pubmed/15985543